OP02. Molecular convergence of CHD7 and BMI1 in medulloblastoma pathogenesis

Autor: Marino Ps, Zhang Dx, Dubuc Da, Taylor Pm

Medulloblastomas (MB) is the most common malignant brain tumour of childhood, and a common cause of pediatric morbidity and mortality. MB have recently been dissected into four distinct molecular subgroups (WNT, SHH, Group 3, Group 4) with divergent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b476fc077d1a2c93cf24556c33ad7d
https://europepmc.org/articles/PMC5358553/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Physiological differences between various types of Eisenmenger syndrome and relation to outcome.

Autor: Moceri P; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; Cardiology Department, Pasteur Hospital, University Hospital of Nice, France., Kempny A; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Liodakis E; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK., Alonso Gonzales R; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Germanakis I; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK., Diller GP; Division of Adult Congenital Disease, Department of Cardiovascular Medicine, University Hospital of Münster, Germany., Swan L; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Marino PS; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Wort SJ; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Babu-Narayan SV; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Ferrari E; Cardiology Department, Pasteur Hospital, University Hospital of Nice, France., Gatzoulis MA; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Li W; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK., Dimopoulos K; Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, UK; NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, UK. Electronic address: k.dimopoulos02@gmail.com.

Publikováno v: International journal of cardiology [Int J Cardiol] 2015 Jan 20; Vol. 179, pp. 455-60. Date of Electronic Publication: 2014 Nov 13.

Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.

Autor: Keir GJ; Princess Alexandra Hospital. Gregory_Keir@health.qld.gov.au., Walsh SL, Gatzoulis MA, Marino PS, Dimopoulos K, Alonso R, Raposeiras-Roubin S, Renzoni EA, Maher TM, Wells AU, Wort SJ

Publikováno v: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2014 Jul 08; Vol. 31 (2), pp. 82-90. Date of Electronic Publication: 2014 Jul 08.

Echocardiographic predictors of outcome in eisenmenger syndrome.

Autor: Moceri P; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom. moceri.p@chu-nice.fr, Dimopoulos K, Liodakis E, Germanakis I, Kempny A, Diller GP, Swan L, Wort SJ, Marino PS, Gatzoulis MA, Li W

Publikováno v: Circulation [Circulation] 2012 Sep 18; Vol. 126 (12), pp. 1461-8. Date of Electronic Publication: 2012 Aug 16.